Skip to main content

Somatostatin for Cluster Headache Attack

  • Conference paper
Updating in Headache

Abstract

Cluster headache (CH) is a hemicraniofacial painful syndrome characterized by ip-silateral miosis and various vasomotor phenomena such as vasodilatation, salivation, nasal secretion, lacrimation and conjunctival congestion. A subpopulation of primary afferent neurons, projecting to the substantia gelatinosa in the spinal cord and to the corresponding area in the nucleus caudalis of the trigeminal nerve was shown to contain somatostatin (SRIF) and substance P (SP). The role of SRIF remains unclear, while that of SP is in the mediation of the antidromic vasodilatation. SP also appears to be the transmitter of pain signals [9]. Opiates and SRIF were capable of blocking the release of SP from both peripheral [2, 11] and central [13] nerve endings. SP induces miosis, edema of the nasal mucosa, vasodilatation. This striking similarity between SP function, trigeminal “topography,” and CH symptoms leads us to try SRIF as a symptomatic therapeutic agent in CH attack.

The investigation was supported by the Italian Research Council (CNR-Rome), finalized project, Preventive and Rehabilitative Medicine (subproject no. 8).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bill A, Stjernshantz J, Mandahl A, Brodin E, Nilsson G (1979) Substance P: release on trigeminal nerve stimulation, effects in the eye. Acta Physiol Scand 47:1–3

    Google Scholar 

  2. Brodin E, Gazelius JM, Lundberg JM, Olgart L (1981) Substance P in trigeminal nerve endings: occurrence and release. Acta Physiol Scand 111: 501–503

    Article  PubMed  CAS  Google Scholar 

  3. Cappelli G, Brocchi A, Strazzulla G, Calabrò A, Ricci OE, Milano M (1983) Methodological approach to the radioimmunoassay of somatostatin. J Nucl Med All Sci 27:1–6

    Google Scholar 

  4. Duckies SP, Buck SM (1982) Substance P in the cerebral vasculature: depletion by capsaicin suggests a sensory role. Brain Res 245:171–174

    Article  Google Scholar 

  5. Gothert M (1980) Somatostatin selectively inhibits noradrenaline release from hypothalamic neurones. Nature 288: 86–88

    Article  PubMed  CAS  Google Scholar 

  6. Guillemin R (1976) Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus. Endocrinology 99:1653–1654

    Article  PubMed  CAS  Google Scholar 

  7. Jancsò G (1981) Intracisternal capsaicin: selective degradation of chemosensitive primary afferents in the adult rat. Neuroscience 27:41–45

    Article  Google Scholar 

  8. Jessel TM (1982) Substance P in nociceptive sensory neurons. In: Porter R, O’Connor M (eds) Substance P in the nervous system (CIBA foundation symposium 91). Pitman, London, pp 206–248

    Google Scholar 

  9. Leeman SE, Gamse R (1981) Substance P in sensory neurons. TIPS May: 119–121

    Google Scholar 

  10. Lembeck F, Holzer P (1979) Substance P as mediator of antidromic vasodilatation and neurogenic plasma extravasation. Naunyn-Schmiedeberg’s Arch Pharmacol 310:175–183

    Article  CAS  Google Scholar 

  11. Lembeck F, Donnerer J, Bartho L (1982) Inhibition of neurogenic vasodilatation and plasma extravasation by Substance P antagonists, somatostatin and D-Met2, Pro5-enkephalinamide. Eur J Pharmacol 85:171–176

    Article  PubMed  CAS  Google Scholar 

  12. Lundblad L, Angard A, Sarim A, Lundberg JM (1983) Substance P and capsaicin in relation to nervous control of blood flow and vascular permeability in the nasal mucosa. In: Powell D, Skrabanek P (eds) Substance P symposium. 27–29 April, Dublin, Ireland, pp 100–101

    Google Scholar 

  13. Randic M, Miletic V (1978) Depressant actions of methionine-enkephalin and somatostatin in cat dorsal horn neurons activated by noxious stimuli. Brain Res 152:196–202

    Article  PubMed  CAS  Google Scholar 

  14. Sicuteri F, Geppetti P, Marabini S, Lembeck F (1983 a) Pain relief by somatostatin in attacks of cluster headache. Pain (in press)

    Google Scholar 

  15. Sicuteri F, Rainò L, Geppetti P (1983b) Substance P and endogenous opioids: how and where they could play a role in cluster headache. Cephalalgia 3 [Suppl 1]: 143–145

    Article  PubMed  Google Scholar 

  16. Scott J, Huskisson EC (1976) Graphic representation of pain. Pain 2:175–184

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Geppetti, P., Brocchi, A., Caleri, D., Marabini, S., Rainò, L., Renzi, D. (1985). Somatostatin for Cluster Headache Attack. In: Pfaffenrath, V., Lundberg, PO., Sjaastad, O. (eds) Updating in Headache. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-88581-5_49

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-88581-5_49

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-15318-4

  • Online ISBN: 978-3-642-88581-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics